medline.ch Gastroenterologie Leber Neoplasie

	Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. Molecules Kono Y, Utsunomiya K, Kariya S, Tanigawa N. PMID: 42738690 [PubMed - indexed for MEDLINE]
	Divergence of the CYB5R3-mARC1 Redox Axis Across the Human MASLD-to-Hepatocellular-Carcinoma Continuum: An Exploratory Analysis of Liver-Biopsy and Tumor Cohorts. Int J Mol Sci Nam SW. PMID: 42737704 [PubMed - indexed for MEDLINE]
	MicroRNA Control of Hepatocyte-Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC. Int J Mol Sci Sartorius K, Kramvis A, Chuturgoon A. PMID: 42737483 [PubMed - indexed for MEDLINE]
	Microbiome-Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma. Int J Mol Sci Ostafe MR, Volovat SR, Clement A, Litcanu CI, Tabarcea SI, Volovat CC, Panaite DI, Augustin IG, Volovat C. PMID: 42737447 [PubMed - indexed for MEDLINE]
	Comprehensive In Silico Analysis Identifies MSTO1 and LIG1 as Candidate Biomarkers With Diagnostic and Prognostic Relevance in Hepatocellular Carcinoma. Cancer Rep (Hoboken) Hamad J, Fayyad-Kazan H, Abdel-Sater F. PMID: 42732946 [PubMed - indexed for MEDLINE]
	The landscape of peripheral blood RNA modifications and its clinical implications for diagnosis of hepatocellular carcinoma. Cell Commun Signal Ge L, Shang M, He X, Cui F, Tao L, Dai S, Wang H, Hu B. PMID: 42732057 [PubMed - indexed for MEDLINE]
	FOLFOX-based transarterial infusion chemotherapy for unresectable colorectal cancer: protocol of an open-label, multicentre, randomised, controlled, phase II trial. BMJ Open Wang J, Sun Y, Chen L, Wang Z, Li K, Guo Y, Yao L, Duan L, Liu Q. PMID: 42731846 [PubMed - indexed for MEDLINE]
	Primary Hepatic Lymphoma with Hepatocellular Carcinoma: A Case Report. J Vis Exp Tang Y, Zhan Y, Xu X, Chen H, Wang J, Jiang Q, Pan Y, Xu J, Li T. PMID: 42730702 [PubMed - indexed for MEDLINE]
	Radiographic evidence of thymic involution in hepatocellular carcinoma: a propensity score-matched study in viral cirrhosis. Front Immunol Li J, Lakang Y, Zuo JX, Li H, Luo WL, Chen XM, Yang ZS, Xu HB, Zhou JY, Liang YB, Wang QB, Li YK, Wang W, Yang C, Guo L, Zhao XX, Ke Y. PMID: 42729300 [PubMed - indexed for MEDLINE]
	Late Ischemic Cholangiopathy After Liver Transplantation From a Deceased Donor With Situs Inversus Totalis: A Case Report. Exp Clin Transplant Meier RPH, Shirini K, Arcerito M, Hirsch J, Alvarez-Casas J, Bhati CS. PMID: 42728710 [PubMed - indexed for MEDLINE]
	Effect of Prior Hilar Manipulation During Previous Hepatectomy on Surgical Outcomes of Laparoscopic Repeat Hepatectomy. Asian J Endosc Surg Arai K, Gon H, Komatsu S, Fukushima K, Urade T, Yoshida T, Nanno Y, Yanagimoto H, Kido M, Fukumoto T. PMID: 42727937 [PubMed - indexed for MEDLINE]
	Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes. Radiol Imaging Cancer Chlorogiannis DD, Bhagavatula SK, Silverman SG, Dabiri BE, Tuncali K, Levesque VM, Gottumukkala RV, Lan Z, Shyn PB. PMID: 42725882 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of tremelimumab plus durvalumab versus sorafenib for unresectable hepatocellular carcinoma in China: an economic evaluation based on five-year overall survival data from the HIMALAYA trial. Front Public Health Feng R, Liang P, Wang Y, Li D, Jia H, Zheng Y, Huo L, Lv Q. PMID: 42723778 [PubMed - indexed for MEDLINE]
	Primary hepatopancreatobiliary lymphoma: epidemiology, clinical features, and treatment outcomes. Sci Rep Shi S, Lin Y, Liu S. PMID: 42722727 [PubMed - indexed for MEDLINE]
	Predictors of Hepatic Decompensation Post-Y90 Treatment in Hepatocellular Carcinoma: New Insights into Segmental TARE and Post-Treatment Dosimetry. J Gastrointest Cancer Afrasiabi A, Gholami B, Moon AM, Villalobos A, Du Pisanie JL, Harris B, Yu H, Mauro D, Varela P, Mohnasky M, Gad S, Kokabi N, FRCPC. PMID: 42720825 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for post-transarterial chemoembolization syndrome in patients with liver cancer: a systematic review protocol. Syst Rev Yang L, Huang S, Sheng X, Xu Q, Ding J. PMID: 42717347 [PubMed - indexed for MEDLINE]
	Robotic repeat hepatectomy for recurrent liver tumors: a systematic review of contemporary evidence and technical strategies. J Robot Surg Machairas N, Kossenas K, Theocharopoulos C, Paspala A, Kykalos S, Sotiropoulos GC. PMID: 42717141 [PubMed - indexed for MEDLINE]
	An MRI-Based Intratumoral and Peritumoral 2.5D Deep Learning Model for Predicting P53-Mutated Hepatocellular Carcinoma: A Two-Center Study. Technol Cancer Res Treat Weng J, Li P, Yao D, He Y, Yang C, Yang B. PMID: 42712103 [PubMed - indexed for MEDLINE]
	Interpretable prediction of macrotrabecular-massive HCC and recurrence-free survival by integrating MRI LI-RADS features with deep learning habitat radiomics. Eur Radiol Exp Zhang M, Wu Q, Zhu M, Zhang T, Gu C, Gu W, Du M, Shen H, Hu C, Yang Y, Wang X, Yu Y. PMID: 42709358 [PubMed - indexed for MEDLINE]
	Harnessing copper-iron crosstalk: A novel strategy to combat hepatocellular carcinoma. Med Oncol Xie X, Cao H, Chen H, Zhang S, Han Z. PMID: 42709356 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 77452

Seite 1 von 3873

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung